PT Kino Indonesia Tbk (IDX:KINO)
1,095.00
0.00 (0.00%)
Aug 5, 2025, 3:36 PM WIB
Sage Therapeutics Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 109,695 | 86,599 | 70,463 | -957,026 | 105,043 | 113,697 | Upgrade |
Depreciation & Amortization | 35,578 | 35,578 | 88,189,295 | 185,797 | 167,232 | 124,660 | Upgrade |
Other Amortization | 10,429 | 10,429 | 9,874 | 9,072 | 5,817 | - | Upgrade |
Other Operating Activities | 356,934 | 275,988 | -87,519,445 | 1,002,681 | 313,628 | -309,539 | Upgrade |
Operating Cash Flow | 512,636 | 408,594 | 750,187 | 240,524 | 591,719 | -71,183 | Upgrade |
Operating Cash Flow Growth | -3.48% | -45.53% | 211.90% | -59.35% | - | - | Upgrade |
Capital Expenditures | -191,008 | -123,699 | -208,088 | -222,108 | -355,947 | -381,230 | Upgrade |
Sale of Property, Plant & Equipment | 7,641 | 7,819 | 106,678 | 32,200 | 17,905 | 2,137 | Upgrade |
Divestitures | - | - | - | - | - | 4,970 | Upgrade |
Sale (Purchase) of Intangibles | -1,533 | -2,900 | -6,726 | -10,706 | -15,946 | -10,825 | Upgrade |
Sale (Purchase) of Real Estate | - | - | - | -56,463 | - | - | Upgrade |
Investment in Securities | -8,576 | -8,576 | -50 | - | - | - | Upgrade |
Other Investing Activities | 407.68 | - | - | - | - | - | Upgrade |
Investing Cash Flow | -193,068 | -127,355 | -108,186 | -257,077 | -353,988 | -384,948 | Upgrade |
Short-Term Debt Issued | - | 483,000 | 280,000 | 1,669,778 | 982,033 | 1,405,885 | Upgrade |
Long-Term Debt Issued | - | - | - | 684,132 | 887,907 | 306,205 | Upgrade |
Total Debt Issued | 474,890 | 483,000 | 280,000 | 2,353,910 | 1,869,940 | 1,712,090 | Upgrade |
Short-Term Debt Repaid | - | -355,000 | -410,000 | -1,465,478 | -1,638,222 | -919,067 | Upgrade |
Long-Term Debt Repaid | - | -300,057 | -299,326 | -483,441 | -281,366 | -108,993 | Upgrade |
Total Debt Repaid | -635,798 | -655,057 | -709,326 | -1,948,919 | -1,919,589 | -1,028,059 | Upgrade |
Net Debt Issued (Repaid) | -160,908 | -172,057 | -429,326 | 404,991 | -49,649 | 684,031 | Upgrade |
Repurchase of Common Stock | - | - | - | -193,458 | - | - | Upgrade |
Common Dividends Paid | -30,334 | -30,334 | - | -13,788 | -34,706 | -147,143 | Upgrade |
Other Financing Activities | -207,241 | -216,567 | -169,636 | -171,400 | -151,526 | -151,717 | Upgrade |
Financing Cash Flow | -398,482 | -418,957 | -598,962 | 26,344 | -235,881 | 385,171 | Upgrade |
Foreign Exchange Rate Adjustments | 4,200 | 5,671 | 4,817 | -14,495 | -4,337 | 3,430 | Upgrade |
Net Cash Flow | -74,714 | -132,048 | 47,855 | -4,704 | -2,486 | -67,529 | Upgrade |
Free Cash Flow | 321,628 | 284,895 | 542,099 | 18,416 | 235,772 | -452,412 | Upgrade |
Free Cash Flow Growth | -25.87% | -47.45% | 2843.63% | -92.19% | - | - | Upgrade |
Free Cash Flow Margin | 7.38% | 6.52% | 13.11% | 0.51% | 5.93% | -11.24% | Upgrade |
Free Cash Flow Per Share | 235.02 | 206.62 | 393.16 | 13.22 | 165.04 | -316.69 | Upgrade |
Cash Interest Paid | 144,098 | 144,098 | 168,624 | 170,735 | 150,226 | 137,914 | Upgrade |
Cash Income Tax Paid | - | -21,337 | -37,177 | 87,487 | 1,872 | 75,294 | Upgrade |
Levered Free Cash Flow | -67,340 | -67,453 | 88,251,478 | 147,367 | 8,637 | -652,608 | Upgrade |
Unlevered Free Cash Flow | 16,892 | 22,608 | 88,356,868 | 254,077 | 106,343 | -566,412 | Upgrade |
Change in Net Working Capital | -48,702 | 14,232 | -217,262 | -765,931 | -167,264 | 430,126 | Upgrade |
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.